149 related articles for article (PubMed ID: 20862685)
1. Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes.
El Mansouri FE; Chabane N; Zayed N; Kapoor M; Benderdour M; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
Arthritis Rheum; 2011 Jan; 63(1):168-79. PubMed ID: 20862685
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade.
Vaillancourt F; Morquette B; Shi Q; Fahmi H; Lavigne P; Di Battista JA; Fernandes JC; Benderdour M
J Cell Biochem; 2007 Apr; 100(5):1217-31. PubMed ID: 17031850
[TBL] [Abstract][Full Text] [Related]
3. Sclareol exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model.
Zhong Y; Huang Y; Santoso MB; Wu LD
Int J Clin Exp Pathol; 2015; 8(3):2365-74. PubMed ID: 26045743
[TBL] [Abstract][Full Text] [Related]
4. COX-2 and iNOS are critical in advanced glycation end product-activated chondrocytes in vitro.
Huang CY; Hung LF; Liang CC; Ho LJ
Eur J Clin Invest; 2009 May; 39(5):417-28. PubMed ID: 19371268
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
[TBL] [Abstract][Full Text] [Related]
6. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.
Kim HA; Cho ML; Choi HY; Yoon CS; Jhun JY; Oh HJ; Kim HY
Arthritis Rheum; 2006 Jul; 54(7):2152-63. PubMed ID: 16802353
[TBL] [Abstract][Full Text] [Related]
7. [Enhanced expression of caveolin-1 in articular chondrocytes in osteoarthritis].
Tang YQ; Shan ZZ; Dai SM
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1493-7. PubMed ID: 18953858
[TBL] [Abstract][Full Text] [Related]
8. Transduction of Cu, Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into human chondrocytes.
Kim HA; Kim DW; Park J; Choi SY
Arthritis Res Ther; 2006; 8(4):R96. PubMed ID: 16792821
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
[TBL] [Abstract][Full Text] [Related]
10. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
Pelletier JP; Fernandes JC; Jovanovic DV; Reboul P; Martel-Pelletier J
J Rheumatol; 2001 Nov; 28(11):2509-19. PubMed ID: 11708426
[TBL] [Abstract][Full Text] [Related]
11. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation.
Alaaeddine N; Olee T; Hashimoto S; Creighton-Achermann L; Lotz M
Arthritis Rheum; 2001 Jul; 44(7):1633-43. PubMed ID: 11465714
[TBL] [Abstract][Full Text] [Related]
12. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
[TBL] [Abstract][Full Text] [Related]
13. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
[TBL] [Abstract][Full Text] [Related]
14. Involvement of inducible nitric oxide synthase and cyclooxygenase-2 in the anti-inflammatory effects of a red orange extract in human chondrocytes.
Frasca G; Panico AM; Bonina F; Messina R; Rizza L; Musumeci G; Rapisarda P; Cardile V
Nat Prod Res; 2010 Sep; 24(15):1469-80. PubMed ID: 20812134
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta.
Kaiser M; Haag J; Söder S; Bau B; Aigner T
Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348
[TBL] [Abstract][Full Text] [Related]
16. Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage.
Vuolteenaho K; Kujala P; Moilanen T; Moilanen E
Scand J Rheumatol; 2005; 34(6):475-9. PubMed ID: 16393772
[TBL] [Abstract][Full Text] [Related]
17. Mechanical strain and TLR4 synergistically induce cell-specific inflammatory gene expression in intestinal smooth muscle cells and peritoneal macrophages.
Wehner S; Buchholz BM; Schuchtrup S; Rocke A; Schaefer N; Lysson M; Hirner A; Kalff JC
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1187-97. PubMed ID: 20829523
[TBL] [Abstract][Full Text] [Related]
18. Carboxymethyl-chitosan protects rabbit chondrocytes from interleukin-1beta-induced apoptosis.
Chen Q; Liu SQ; Du YM; Peng H; Sun LP
Eur J Pharmacol; 2006 Jul; 541(1-2):1-8. PubMed ID: 16740257
[TBL] [Abstract][Full Text] [Related]
19. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide.
Boileau C; Martel-Pelletier J; Moldovan F; Jouzeau JY; Netter P; Manning PT; Pelletier JP
Arthritis Rheum; 2002 Oct; 46(10):2637-47. PubMed ID: 12384922
[TBL] [Abstract][Full Text] [Related]
20. TGFbeta inhibits IL-1 -induced iNOS expression and NO production in immortalized chondrocytes.
Vuolteenaho K; Moilanen T; Jalonen U; Lahti A; Nieminen R; van Beuningen HM; van der Kraan PM; Moilanen E
Inflamm Res; 2005 Oct; 54(10):420-7. PubMed ID: 16283110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
